Contributions of age groups and causes of death to the sex gap in lifespan variation in Europe.


Journal

Population studies
ISSN: 1477-4747
Titre abrégé: Popul Stud (Camb)
Pays: England
ID NLM: 0376427

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 3 11 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Much less is known about the sex gap in lifespan variation, which reflects inequalities in the length of life, than about the sex gap in life expectancy (average length of life). We examined the contributions of age groups and causes of death to the sex gap in lifespan variation for 28 European countries, grouped into five European regions. In 2010-15, males in Europe displayed a 6.8-year-lower life expectancy and a 2.3-year-higher standard deviation in lifespan than females, with clear regional differences. Sex differences in lifespan variation are attributable largely to higher external mortality among males aged 30-39, whereas sex differences in life expectancy are due predominantly to higher smoking-related and cardiovascular disease mortality among males aged 60-69. The distinct findings for the sex gap in lifespan variation and the sex gap in life expectancy provide additional insights into the survival differences between the sexes.

Identifiants

pubmed: 37366162
doi: 10.1080/00324728.2023.2222723
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

475-496

Auteurs

Jesús-Daniel Zazueta-Borboa (JD)

Netherlands Interdisciplinary Demographic Institute-KNAW.

José Manuel Aburto (JM)

London School of Hygiene and Tropical Medicine.
University of Oxford.
University of Southern Denmark.

Iñaki Permanyer (I)

ICREA.
Centre for Demographic Studies (CED-CERCA), Autonomous University of Barcelona.

Virginia Zarulli (V)

University of Southern Denmark.

Fanny Janssen (F)

Netherlands Interdisciplinary Demographic Institute-KNAW.
University of Groningen.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH